Filing Details

Accession Number:
0000950103-25-007790
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-25 06:03:05
Reporting Period:
2025-06-23
Filing Date:
2025-06-25
Accepted Time:
2025-06-25 06:03:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014763 Ainos Inc. AIMD Pharmaceutical Preparations (2834) 751974352
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2021793 Ase Test, Inc. 10 West Fifth Street, Nanzih District
Kaohsiung F5 00000
No No Yes No
Transaction Summary
Purchased: 29,476 shares Avg. Price: $0.00 Total Value: $0.00
Number of Shares After Transactions: 58,887 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2025-06-23 29,476 $0.00 58,887 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. ASE Test, Inc. ("ASE Test"), the reporting person acquired the shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") pursuant to the Share Exchange Agreement that was made and entered into as of June 3, 2025 by and between ASE Test and Taiwan Carbon Nano Technology Corporation, in exchange for 5,687,109 ordinary shares of Ainos Inc., a Cayman Islands company, having an approximate fair market value of $0.497 per share.
  2. The shares of Common Stock of the Issuer reported herein are directly held by ASE Test, an indirectly wholly-owned subsidiary of ASE Technology Holding Co., Ltd. Accordingly, ASE Technology Holding Co., Ltd. is reporting indirect ownership of the securities held by ASE Test.